SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000819050-21-000175
Filing Date
2021-12-14
Accepted
2021-12-14 17:13:39
Documents
13
Period of Report
2021-12-14
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K bbi-20211214.htm   iXBRL 8-K 34141
5 bbi-20211214_g1.jpg GRAPHIC 6568
  Complete submission text file 0000819050-21-000175.txt   192071

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20211214.xsd EX-101.SCH 1909
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20211214_lab.xml EX-101.LAB 25154
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20211214_pre.xml EX-101.PRE 13055
6 EXTRACTED XBRL INSTANCE DOCUMENT bbi-20211214_htm.xml XML 11253
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 211491890
SIC: 2836 Biological Products, (No Diagnostic Substances)